General Information

The IIS Aragón International Projects Office aims to support and promote research on health issues in R&D&I funding programs inside and outside the EU.

Its main functions are:

Identification and dissemination of calls for different European and international programs for the financing of R&D&I projects.
Organization of conferences to disseminate opportunities for participation in European and international R&D&I programs.
Support to IIS Aragón researchers in the search for partners and opportunities to participate in project proposals.
Support to IIS Aragón researchers in the preparation of project proposals, both in the administrative part and in the preparation of the budget, as well as verification of compliance with the requirements demanded in each call.
Support to IIS Aragón researchers in the preparation and writing of project proposals in which they participate as coordinator.
Economic and administrative management of approved projects.
Support to researchers in the organization of conferences and events linked to ongoing projects.
Communication with the National Contact Points (NCP) or with the Commission, if applicable, to clarify any doubts that may arise in the preparation of the proposals or the execution of the projects themselves.

For more information, you can contact us at international@iisaragon.es.

Programs

Horizon Europe (2021 – 2027)

Horizon Europe (HE) is the new research and innovation (R&I) framework program of the European Union (EU) for the period 2021 -2027, a fundamental instrument to carry out the EU's R&D&I policies. .

El target general of the program is:
●    Strengthen the scientific and technological bases of the EU and the European Research Area (ERA).
●    Boost Europe's innovation capacity, competitiveness and employment.
●    Comply with citizens' priorities, as well as sustain our values and socioeconomic model.

The Commission has a budget of approximately €100 billion for HE, making it the largest budgeted framework program to date, with the potential to generate significant economic, social and scientific benefits.

Horizon Europe Guides:
Horizon Europe Participant Guide
Horizon Europe Quick Guide

Pages of interest:
Horizon Europe (sp)
Horizon Europe (en)

Scheme:

Pillar 1 – EXCELLENT SCIENCE
It aims to increase the global scientific competitiveness of the European Union.

European Research Council (ERC): support for excellent researchers and its teams with the aim of pursuing innovations of high risk and high benefit in any field of research, with scientific excellence being the only evaluation criterion.
Marie Sklodowska Curie Shares (MSCA) : I support training and professional development of research staff from around the world through funding excellent doctoral programs, individual postdoctoral projects and collaborative projects.
Research Infrastructures (RI): Empower Europe through an integrated ecosystem of world-class research and technological infrastructure, open and accessible so that all researchers can harness their potential for scientific advancement and innovation.

Pillar 2 - GLOBAL CHALLENGES AND EUROPEAN INDUSTRIAL COMPETITIVENESS
It aims to generate knowledge, intensify the impact of research and innovation (R&I) on the development and implementation of EU policies, as well as support for these policies, and promote access to and adoption of solutions. innovative in European industry, especially SMEs, and in society, facing global challenges.

Within this pillar we highlight, due to the relevance it has for the IIS Aragón, the Health Cluster, whose main objective is to improve and protect the health and well-being of citizens to prevent, diagnose, monitor, treat and cure diseases, develop health technologies and achieve more sustainable public health systems.

This objective is conveyed through 6 areas of intervention (destinations), within which calls are coming out:

Health throughout life
Environmental and social determinants of health and well-being
Non-communicable diseases and rare diseases
Infectious diseases, including poverty-associated and neglected diseases
Digital tools, technologies and solutions for health and care, including personalized medicine
Health care systems

Pillar 3 - INNOVATIVE EUROPE
Designed to deliver tangible results to lead a wave of breakthrough innovation, addressing challenges such as increasing venture funding, access to and transfer of research results, accelerating business transformation, and addressing fragmentation of the innovation ecosystem.

European Innovation Council (EIC): HE one-stop shop for all types of innovators, from individuals to universities, research organizations and companies (SMEs, including start-ups and, in exceptional cases, small mid-caps).
European Innovation Ecosystems (EIE): creation of more connected and efficient innovation ecosystems to support the scaling of companies, foster innovation and stimulate cooperation between national, regional and local innovation actors.
European Institute of Innovation and Technology (EIT): EIT is Europe's largest innovation community that connects and enhances the knowledge triangle (education, business and research) of the continent to create products and services that solve society's challenges. Within the field of health, we find the EITHealth, with the aim of offering solutions that allow European citizens to live longer and healthier lives by promoting innovation.

EXPAND PARTICIPATION AND STRENGTHEN THE EUROPEAN RESEARCH AREA
This part of the program supports the geographic diversity, building the necessary capacities to enable successful participation in the R&I process, promoting networks of contacts and access to excellence, consequently, optimizing the impact of pillar 2 “Global challenges” and seeking synergies with pillar 3 “Europe”. Innovative.” Furthermore, this part of the program aims to advance the dissemination and exploitation of research results, reinforcing the interaction between education and research, and strengthening the collaboration across Europe opening up to European R&I networks.

To do this, this program is divided into two large sections:

Expand participation and spread Excellence (Widening): The objective is to expand networks of excellence, including countries and regions that are less advanced in R&D&I systems, making them stronger and allowing the EU as a whole to advance together.
Reform and improve the European Research and Innovation system (ERA): Based on the ERA policy priorities, it seeks to restructure the European research landscape towards greater cross-border cooperation, coordination of research policies and activities at European and national level, encourage the free movement of research personnel, scientific knowledge and innovation, the development of a critical mass of researchers and positioning Europe as a global pole of reference in this field.

CANCER MISSION
The Horizon Europe program launches the Missions, created as a new way of providing concrete solutions to some of our greatest challenges, better linking European R&D&I to the needs of society and citizens. The missions have ambitious goals and the objective of delivering tangible results by 2030.
The CANCER MISSION proposes as a global objective advances in the next decade that allow save at least 3 million lives in Europe. In general terms, look for:
To do this, this program is divided into two large sections:

Extend the life expectancy of cancer patients
Achieve a higher quality of life for patients, survivors and the family environment
Consolidate mechanisms that prevent or delay the onset of the disease.

To achieve these objectives, it has detailed 5 areas of intervention: on the one hand, the 3 pillars of (2) prevention, (3) diagnosis and treatment and (4) quality of life, and transversally the areas of (1) comprehensive understanding of the disease and (5) equitable access to all interventions developed in all EU countries.

PARTNERSHIPS / EUROPEAN HEALTH ASSOCIATIONS
European partnerships are initiatives in which the EU Commission and private and/or public partners commit to jointly support the development and implementation of a research and innovation programme.

Types of associations:

Co-financed: public collaboration (CE) + public (country: in this case it is usually through the ISCIII or the AEI of the Ministry). Successors of the EJP and ERA-NET cofund initiatives.
Institutional: public (CE) + public (institutions) collaboration. Successors of the EIT's Joint Undertaking Technologies and Knowledge Innovation Communities (KIT) initiatives.
Co-scheduled: public (CE) + private collaboration (industrial associations or private partners). Successors of contractual public-private partnerships (PPP).

LIST OF PARTNERSHIPS / HEALTH-RELATED ASSOCIATIONS
Pillar		Association Type	Association name
2	Health cluster	Co-financed	PARC: Chemical Risk Assessment (formerly Human Biomonitoring for Europe – HBM4EU). ERA4Health: Fostering an ERA for Health Research (formerly ERA-Nets) Health and Care Systems Transformation (formerly EIP on AHE and AAL) PerMed: Personalized Medicine (formerly IC PerMed) Rare diseases (formerly JPI-Rare Diseases). One Health AMR: Antimicrobial Resistance (formerly JPI-AMR). Pandemic preparedness
	Health cluster	Institutional	EU-AFRICA Global Health (formerly EDCTP: European & Developing Countries Clinical Trials Partnership). IHI: Innovative Health Initiative (formerly IMI: Innovative Medicines Initiatives).
	Cluster Digital world, industry and space	Institutional	KDT: Key Digital Technologies (continued from JTI ECSEL)
3	EIT	Institutional	EITHealth

Eu4health

EU4Health or UEproSalud is the EU's ambitious response to COVID-19. The pandemic has significant repercussions on patients, medical and healthcare personnel, and healthcare systems in Europe. The new EU4Health program (2021-2027) will go beyond crisis response to address the resilience of health systems.

The general objectives of Eu4Health are described below, together with its specific objectives:

Improve and promote health in the Union

Disease prevention and health promotion
International initiatives in health and cooperation

Tackling cross-border health threats

Prevention, preparedness and response to cross-border health threats
Supplement national storage of essential products related to the crisis
Create a reserve of medical, healthcare and support personnel

Improve medicines, health products and crisis-relevant products

Provide medicines, health products and products relevant to the crisis, and ensure they are affordable.

Strengthen health systems, their resilience and resource efficiency

Strengthen health data, digital tools and services, digital transformation of healthcare
Improve access to healthcare
Develop and implement EU health legislation and make evidence-based decisions
Integrated work between national health systems

POCTEFA

POCTEFA is the European INTERREG Spain-France-Andorra territorial cooperation program created to promote the sustainable development of the border territory between the three countries.

Progress in the writing of the POCTEFA 2021-2027

The Management Authority of the Interreg VI-A Spain-France-Andorra Cross-border Cooperation Program (POCTEFA) has sent to the European Commission, dated September 30, 2022, the following elements of the POCTEFA 2021-2027 Program:

Final version of the program and POCTEFA map 2021-2027
● Annex 1: Indicator methodology
● Annex 2: Synthetic tables of indicators
● Annex 3: Indicator calculation parameters
● Annex 4: Introduction Functional Areas: general map and index
● Annex 5: West functional area
● Annex 6: Center functional area
● Annex 7: Mountain Territory functional area Eastern Zone
● Annex 8: Functional area Catalan Cross-border Space
● Annex 9: Eastern Coast functional area

Other documents related to the program are:
●   Strategic environmental study
●   Non-technical summary of the Strategic Environmental Study
●   Strategic Environmental Statement (Resolution of June 23, 2022, of the General Directorate of Quality and Environmental Assessment of the Ministry for the ecological transition and the demographic challenge).

POCTEFA territory map 2021-2027

Political objectives, priorities and specific objectives of POCTEFA 2021-2027

Public consultations on the POCTEFA 2021-2027 Program
En this section You can find out all the information regarding public consultations on the INTERREG VI-A Spain-France-Andorra program (POCTEFA 2021-2027).

PUBLIC CONSULTATIONS

At the moment there is no date for the next calls for projects. To receive information about this, sign up for our newsletter here. Below, you can consult some relevant documents for the period 2021-2027.

As part of the progress in the process of creating the POCTEFA 2021-2027 Program, the Spanish Environmental Authority issued a scope document in February 2021 that is available here.

Regulations for the period 2021-2027:
ERDF Regulation
INTERREG Regulation.
Common Regulations (CPR)

International Calls

CAAT Reduction Grant 2024

11-09-2024

Starting Grants in ALS Basic Research 2024

10-09-2024

Transnational Service Provision

09-09-2024

Leo Foundation Research Grants in open competition – Call 3

29-08-2024

Global Grants for Gut Health 2024

29-08-2024

Call for multilateral projects with the United States with the participation of the AEI in the framework of computational neuroscience